We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Enzon Pharmaceuticals Inc.s financial performance into perspective.
| Enzon Pharmaceuticals Inc. (NASDAQ: ENZN) | 4:00 PM ET on Sep 2, 2010 | |||
|---|---|---|---|---|
| Last Price | Change | Open | Day High | 52-Week High |
10.58 |
0.17
(1.633%) |
10.47 | 10.60 | 11.60 |
| Volume | Previous Close | Day Low | 52-Week Low | |
| 208,700 | 10.41 | 10.44 | 7.34 | |
Convert chart to Excel
Sign up for email alerts
The stock information provided is for informational purposes only and is not intended for trading purposes. The stock information is provided by eSignal, stock charts are provided by EDGAR Online, both third party services, and Enzon Pharmaceuticals Inc. does not maintain or provide information directly to this service. Stock information is delayed approximately 20 minutes.
| (ENZN) NASDAQ | |
| Last Trade | 10.580 |
| Change(%) |
0.17
|
| Volume | 208,700 |
| Sep 2, 2010 4:00 PM ET | |
Sign up to receive Enzon Pharmaceuticals Inc. financial information by email.
News
Details on upcoming events are not yet available.
click here to be notified of all upcoming events.


Really Simple Syndication is a format designed for sharing web content such as headlines. An RSS feed highlights fresh material for you, so you don't have to repeatedly check a site yourself for updates.
Company continues to progress as an innovative oncology
development company
--Company is transformed to be exclusively focused on its pipeline--
